LEVELS OF GROWTH FACTORS AND THEIR RECEPTORS IN INTACT AND TUMOR TISSUES OF FEMALE MICE IN DYNAMICS OF THE MALIGNANT MELANOMA GROWTH
- Authors: Kit O.I1, Frantsiyants E.M1, Bandovkina V.A.1, Kaplieva I.V1, Trepitaki L.K1, Rozenko L.Y.1, Cheryarina N.D1, Pogorelova Y.A1, Shulga A.V1
-
Affiliations:
- Rostov Research Institute of Oncology
- Issue: Vol 22, No 5 (2017)
- Pages: 281-287
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40397
- DOI: https://doi.org/10.18821/1028-9984-2017-22-5-281-287
- ID: 40397
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O. I Kit
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
E. M Frantsiyants
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
Valeriya A. Bandovkina
Rostov Research Institute of Oncology
Email: super.gormon@yandex.ru
MD, PhD, Senior Researcher of the Laboratory of Pathogenesis of Malignant Tumors, Rostov-on-Don, 344037, Russian Federation. 344037, Rostov-on-Don, Russian Federation
I. V Kaplieva
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
L. K Trepitaki
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
L. Ya Rozenko
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
N. D Cheryarina
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
Yu. A Pogorelova
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
A. V Shulga
Rostov Research Institute of Oncology344037, Rostov-on-Don, Russian Federation
References
- Чехонин В.П., Шеин С.А., Корчагина А.А., Гурина О.И. Роль VEGF в развитии неопластического ангиогенеза. Вестник РАМН. 2012; (2): 23-33.
- Ferrara N., Gerber H.P., Le Couter J. The biology of VEGF and its receptors. Nature Med. 2003; 9 (6): 669-76.
- Wang X., Chen X., Fang J., Yang C. Over expression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth. Int. J. Clin. Exp. Pathol. 2013; 6(4): 586-97.
- Capoluongo E., Ameglio F., Zuppi S. Insulin-like growth factor-I and complications of prematurity: Focus on bronchopulmonary dysplasia. Clin. Chem. Lab. Med. 2008; 46: 1061-6.
- Roddam A.W., Allen N.E., Appleby P., Key T.J., Ferrucci, Carter H.B. et al. (2008), Insulin like growth factors and their binding proteins, and the risk of prostate cancer: Analysis of individual patient data from 12 prospective studies. Ann. Intern. Med. 2008; 149: 461-71.
- Duffy M.J., O,Donovan N., Grown J. Use of molecular markers for predicting therapy response in cancer patients. J. Cancer Treatment Reviews. 2011; 37(2):151-9. doi: 10.1016/j.ctrv.2010.07.004.
- Bracher A., Cardona A.S., Tauber S., Fink A.M., Steiner A., Pehamberger H. et al. Epidermal growth factor promotes melanoma lymph node metastasis by acting on tumor lymphangiogenesis. J. Invest. Dermatol. 2013; 133(1): 230-8. DOI: 10.1038 /jid.2012.272. Epub 2012 September 6th.
- Akslen L.A., Puntervoll H., Bachmann I.M., Straume O., Vuhahula E., Kumar R., Molven A. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanoma from black Africans and other subgroups of cutaneous melanoma. Melanoma Res. 2008; 18(1): 29-35. doi: 10.1097/CMR.0b013e3282f32517
- Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGF-beta activation. J. Cell. Sci. 2003; 116: 217-24.
- Javelaud D., Alexaki V.I, Mauviel A. Transforming growth factor-BETA in cutaneous melanoma. Pigment Cell Melanoma Res. 2008; 21(2): 123-32. DOI: 10.1111 / j.1755-148X.2008.00450.x
- Santos Bernardes S., de Souza-Neto F.P., Melo G.P., Guarnier F.A., Marinello P.C., Cecchini R., Cecchini A.L. Correlation of TGF-β1 and oxidative stress in the blood of patients with melanoma: a clue to understanding melanoma progression? Tumour Biol. 2016; 37(8): 10753-61.
- Cantelli G., José L., Rodriguez-Hernandez I., Karagiannis P., Maiques O., Matias-Guiu X. et al. TGF-β-induced transcription Braves Melanoma amoeboid migration and proliferation. Curr. Biol. 2015; 25(22): 2899-914. DOI: 10.1016 / j.cub.2015.09.054. PMCID: PMC4651903
- Choi M., Moschetta A., Bookout A.L., Peng L., Umetani M., Holmstrom S.R. et al. Definition of a hormonal basis for filling the gallbladder. Nat. Med. 2006; 12: 1253-5.
- Chow M.D.L., Gao J., Qing Y., Zhidan W., Gromada J. Fibroblast growth factor 21 regulates energy metabolism through activation of AMPK-SIRT1-PGC-1alpha pathway. Proc. Nat. Acad. Sci. USA. 2010; 107(28): 12553-8. DOI: 10.1073 / pnas.1006962107 PMCID: PMC2906565
- Hori M., Shimizu Y., Fukumoto S. Minireview: fibroblast growth factor-23 in phosphate homeostasis and bone metabolism. Endocrinology. 2011; 152: 4-10.
- Feng S., Dakhova O., Creighton C.J., Ittmann M. Endocrine FGF19 fibroblast growth factor promotes the development of prostate cancer. Cancer Res. 2013; 73(8): 2551-62. DOI: 10,1158 / 0008-5472.CAN-12-4108
- Франциянц Е.М., Бандовкина В.А., Каплиева И.В., Трепитаки Л.К., Погорелова Ю.А., Черярина Н.Д. Факторы роста эндотелия сосудов и рецепторов в динамике развития перевиваемой меланомы B16/F10. Российский онкологический журнал. 2015; 20(2): 32-7.
- Treshchalina E.M., Zhukova O.S., Gerasimova G.K., Andronova N.V., Garin A.M. The guidelines for conducting pre-clinical testing of medicines. M.: Grif i K; Ch.1. 2012: 642-57.
- Vartanian A. Signaling pathways in tumor vasculogenic mimicry. Biochemistry. 2012; 77(9): 1044-55.
- Zeng Y., Opeskin K., Goad J., Williams T.D. Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis. Cancer Res. 2006; 66(1): 9566-75.
- He Y., Rajantie I., Ilmonen M., Makinen T., Karkkainen M.J., Haiko P. et al. Preexisting Lymphatic Endothelium but not Endothelial Progenitor Cells Are Essential for Tumor Lymphangiogenesis and Lymphatic Metastasis. Cancer Research. 2004; (64): 3737-40.
- Lee S., Safdie F.M., Raffaghello L., Wei M., Madia F., Parrella E., Hwang J., Cohen P. Reduced levels of IGF-I mediates the differential protection of normal and cancer cells in response to the post and improve the chemotherapeutic index. Cancer Res. 2010; 70: 1564-72.
- Satyamoorthy K., Li G., Vaidya B., Kalabis J.M. Herlin insulin-like growth factor-I-induced migration of melanoma cells is mediated by IL-8 induction. The growth of the cells are different. 2002; 13: 87-93.
- Pollack M. Insulin and insulin-like growth factor-like signaling in neoplasia. Nature Rev. Cancer. 2008; 8: 915-28.
- Бабышкина Н.Н., Малиновская Е.А., Стахеева М.Н., Волкоморов В.В., Уфандеев А.А., Слонимская Е.М. Роль трансформирующего ростового фактора TGF-β1 в патогенезе рака молочной железы. Сибирский онкологический журнал. 2010; 6: 42: 63-70.
- Humbert L., Ghozlan M., Canaff L., Tian J., Lebrun J.J. Leukemia inhibitory factor (LIF) and p21 mediates tumor TGF-beta-suppressing effects in the skin of human melanoma. BMC Cancer. 2015; 15: 200. DOI: 10,1186/ s12885-015-1177-1
- Tan M.R., Wang Y.X., Guo S., Han S.Y., Li H.H., Jin S.F. Prognostic value of plasma and at levels of transforming growth factor beta 1, -2 and -3 in cutaneous melanoma. Mol. Med. Rep. 2015; 11(6): 4508-12. DOI: 10,3892 / mmr.2015.3250. Epub 2015 Jan. 26